Table 7.
AFFF (%) | PFOS () | |||
---|---|---|---|---|
16 | 32 | |||
( PFOS) | ( PFOS) | () | () | |
Liver length | Decrease | Decrease | — | — |
Beta cell islet area | — | — | — | Decrease |
Beta cell aberrant morphology | — | — | — | — |
Exocrine pancreas length | — | — | — | Decrease |
Stunted exocrine pancreas morphology | — | Increase | NT | NT |
Note: All AFFF data and PFOS liver data are from the present study. PFOS pancreatic data are summarized from Sant et al. 2017, 2019. —, no effect; AFFF, aqueous film-forming foam; NT, not tested; PFOS, perfluorooctanesulfonic acid.